The Oncology Drugs Global Market Report 2021-31 by The Business Research Company describes and explains the global oncology drugs market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
The Oncology Drugs Global Market Report 2022 covers oncology drugs market drivers, oncology drugs market trends, oncology drugs market segments, oncology drugs market growth rate, oncology drugs market major players, and oncology drugs market size.
View Complete Report:
The oncology drugs market report provides in-depth analysis of the impact of COVID-19 on the global oncology drugs industry along with revised market numbers due to the effects of the coronavirus and the expected oncology drugs market growth numbers for 2022-2031.
The global oncology drugs market size is expected to grow from $199.95 billion in 2021 to $223.21 billion in 2022 at a compound annual growth rate (CAGR) of 11.6%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The oncology drugs market share is expected to reach $540.60 billion in 2026 at a CAGR of 24.8%
Request Report Sample Now:
Oncology Drugs Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
TBRC’s report covers the oncology drugs market segments-
1) By Type: Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
The table of contents in TBRC’s oncology drugs market report includes:
1. Executive Summary
2. Report Structure
3. Oncology Drugs Market Characteristics
4. Oncology Drugs Market Product Analysis
5. Oncology Drugs Market Supply Chain
21. Key Mergers And Acquisitions In The Oncology Drugs Market
22. Market Background: Pharmaceutical Drugs Market
25. Copyright And Disclaimer
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Find us on
Oncology Drugs Market, Industry Trends, Revenue Growth, Key Players Till 2031
717 Views|3 months ago|